In " Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how ...

Prevalence rates of chronic lymphocytic leukemia have steadily increased over the last 30 years, and are projected to continue to rise. Survival rates have steadily increased among all age groups ...

Please provide your email address to receive an email when new articles are posted on . Fixed-duration acalabrutinib plus venetoclax improved outcomes for untreated chronic lymphocytic leukemia ...

Chronic lymphocytic leukemia (CLL) is a type of blood cancer that affects white blood cells called lymphocytes. There are many types of leukemia, and CLL is a common type in adults. This type of ...

NEW ORLEANS — One of the best therapies for some types of lymphoma and leukemia has been a drug called ibrutinib, made by AbbVie. When it hit the market in 2013, the drug revolutionized the treatment ...

Share on Pinterest Researchers are hopeful a three-drug combination can be effective in the treatment of chronic lymphocytic leukemia. Phynart Studio/Getty Images Chronic lymphocytic leukemia can be ...

Remission is good news. It means most or all signs of your cancer are gone. In some types of cancer, remission may turn into a lasting cure. But when you have chronic lymphocytic leukemia (CLL), your ...

A retrospective observational study of rapid titration of venetoclax (VEN) in patients with mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL). This is an ASCO Meeting Abstract from the ...

Though it may not cause symptoms for everyone, preventing the spread of lymphocytic choriomeningitis (LCM) is important to keeping everyone in our community safe. Share on Pinterest twpixels/Getty ...